January 5, 2009 08:48 AM EDT

FDA approves fenofibric acid for lipid target controls

The FDA approved the new drug application of a new formulation of fenofibric acid — the first and only fibrate indicated for use in combination with a statin, according to a press release.

Fenofibric acid (Trilipix, Abbott) is manufactured as delayed-release 45-mg and 13...

FULL STORY

Calendar
April 21, 2009

Pacific Coast Reproductive Society 2009

Indian Wells, ca United States of America

more information »

Quote of the day

"Like most of my endocrinologist peers, I believe that desiccated thyroid is antiquated therapy and should no longer be used..."

Click here to read full entry. »

Featured Story

HAPO results reveal that a mother’s glucose level directly affects pregnancy outcomes

Physicians who treat women with gestational diabetes marked an important milestone in May. The long-awaited Hyperglycemia and Adverse Pregnancy Outcomes results, first presented at the 2007 Annual Meeting of the American Diabetes Association, were published in The New England Journal of Medicine. Since then, HAPO researchers from around the world have sought a consensus in diagnosing the disease. The HAPO results showed strong associations between the m...

FULL STORY

Endocrine Today by the numbers
BP Profiles of Children with Type 1 Diabetes
By the numbers
[+] more information »